Lenalidomide N-Glucoside

Product Description
CAT No.
ALN-L031005
CAS No.
NA
Mol. F.
C19H23N3O8
Mol. Wt.
421.4
Stock
Please Inquire
Product Overview
Technical Data
Reference
RFQ
Product Overview
Chemical Name : 3-(4-Amino-1-oxoisoindolin-2-yl)-1-((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)piperidine-2,6-dione
Smiles : NC1=CC=CC2=C1CN(C(CC3)C(N([C@H]4O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]4O)C3=O)=O)C2=O
Inchi : InChI=1/C14H13N3O4/c18-7-15-10-3-1-2-8-9(10)6-17(14(8)21)11-4-5-12(19)16-13(11)20/h1-3,7,11H,4-6H2,(H,15,18)(H,16,19,20)
Technical Data
Reference
Determination of possible potential genotoxic impurities in lenalidomide drug substance by simple RP-HPLC method
By Gaddam, Kishore; Kanne, Shanker; Gundala, Trivikram Reddy; Mamilla, Yogeshwar Reddy; Chinna, Gangi Reddy NallagondunFrom Asian Journal of Chemistry (2020), 32(12), 2965-2970
Development and validation of stability-indicating RP-HPLC method for the estimation of lenalidomide and its impurities in oral solid dosage form
By Prasad, Somana Siva; Mohan, G. V. Krishna; Babu, A. Naga – From Oriental Journal of Chemistry (2019), 35(1), 140-149
Simultaneous quantification of lenalidomide, ibrutinib and its active metabolite PCI-45227 in rat plasma by LC-MS/MS: Application to a pharmacokinetic study
By Veeraraghavan, Sridhar; Viswanadha, Srikant; Thappali, Satheeshmanikandan; Govindarajulu, Babu; Vakkalanka, Swaroopkumar; Rangasamy, Manivannan – From Journal of Pharmaceutical and Biomedical Analysis (2015), 107, 151-158
RFQ